Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5177999
Max Phase: Preclinical
Molecular Formula: C28H34N2O11
Molecular Weight: 574.58
Associated Items:
ID: ALA5177999
Max Phase: Preclinical
Molecular Formula: C28H34N2O11
Molecular Weight: 574.58
Associated Items:
Canonical SMILES: C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)[C@H]1CC(=O)c1[nH]c2ccccc2c1CC(=O)NC
Standard InChI: InChI=1S/C28H34N2O11/c1-4-13-15(9-19(32)22-16(10-21(33)29-2)14-7-5-6-8-18(14)30-22)17(26(37)38-3)12-39-27(13)41-28-25(36)24(35)23(34)20(11-31)40-28/h4-8,12-13,15,20,23-25,27-28,30-31,34-36H,1,9-11H2,2-3H3,(H,29,33)/t13-,15+,20-,23-,24+,25-,27+,28+/m1/s1
Standard InChI Key: MQYTVGQFZUKBAG-LPPJHQBOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 574.58 | Molecular Weight (Monoisotopic): 574.2163 | AlogP: -0.32 | #Rotatable Bonds: 10 |
Polar Surface Area: 196.87 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.93 | CX Basic pKa: | CX LogP: -0.70 | CX LogD: -0.70 |
Aromatic Rings: 2 | Heavy Atoms: 41 | QED Weighted: 0.12 | Np Likeness Score: 1.39 |
1. Shi BB, Ai HL, Duan KT, Feng T, Liu JK.. (2022) Ophiorrhines F and G, Key Biogenetic Intermediates of Ophiorrhine Alkaloids from Ophiorrhiza japonica and Their Immunosuppressant Activities., 85 (2.0): [PMID:35104138] [10.1021/acs.jnatprod.1c01085] |
Source(1):